Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets
Bristol-Myers Squibb Deferred Tax Assets and Other Non-Current Assets decreased by 6.1% to $6.08B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 3.7%, from $5.87B to $6.08B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows relatively stable performance with a -1.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryLiquidity
SignalContext dependent
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.
Detailed definition
This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...
Peer comparison
Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.
Metric ID:
deferred_tax_assets_other_noncurrentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.45B | $7.40B | $5.54B | $4.85B | $4.73B | $4.75B | $4.94B | $4.87B | $5.02B | $5.21B | $5.37B | $6.02B | $6.07B | $6.04B | $6.11B | $5.87B | $5.94B | $6.33B | $6.47B | $6.08B |
| QoQ Change | — | +14.7% | -25.2% | -12.5% | -2.4% | +0.4% | +4.1% | -1.5% | +3.2% | +3.8% | +3.0% | +12.2% | +0.8% | -0.4% | +1.0% | -3.9% | +1.2% | +6.7% | +2.2% | -6.1% |
| YoY Change | — | — | — | — | -26.7% | -35.9% | -10.7% | +0.5% | +6.2% | +9.9% | +8.7% | +23.7% | +20.9% | +15.9% | +13.7% | -2.6% | -2.2% | +4.8% | +6.0% | +3.7% |
Range$4.73B – $7.40B
CAGR-1.2%
Avg YoY Growth+2.2%
Median YoY Growth+5.4%
Deferred Tax Assets and Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's deferred tax assets and other non-current assets?
- Bristol-Myers Squibb (BMY) reported deferred tax assets and other non-current assets of $6.08B in Q1 2026.
- How has Bristol-Myers Squibb's deferred tax assets and other non-current assets changed year-over-year?
- Bristol-Myers Squibb's deferred tax assets and other non-current assets increased by 3.7% year-over-year, from $5.87B to $6.08B.
- What is the long-term trend for Bristol-Myers Squibb's deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's deferred tax assets and other non-current assets has grown at a -1.6% compound annual growth rate (CAGR), from $7.02B to $6.47B.
- What does deferred tax assets and other non-current assets mean?
- The total value of long-term tax assets and other miscellaneous long-term assets.